Prognostic Value of Arterial Spin Labeling Brain Perfusion MRI in Term Neonates With Hypoxic-ischemic Encephalopathy
NCT04325230 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31
Last updated 2023-04-28
Summary
The main purpose of this study will be to evaluate the prognostic value at 3 months of life of brain perfusion MRI determined by Arterial Spin Labeling technique in the first week of life of term newborns with hypoxic-ischemic encephalopathy requiring management in neonatal intensive care unit.
Conditions
- Neonatal Hypoxic Ischemic Encephalopathy
Interventions
- DEVICE
-
Arterial Spin Labeling sequence
ASL sequence added to the usual care brain MRI
Sponsors & Collaborators
-
University Hospital, Bordeaux
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Day
- Max Age
- 8 Days
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-17
- Primary Completion
- 2023-01-12
- Completion
- 2023-01-12
Countries
- France
Study Locations
More Related Trials
-
Neuroprotective Effect of Autologous Cord Blood Combined With Therapeutic Hypothermia Following Neonatal Encephalopathy
NCT02551003 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
MRI of Neonate With HIE Before and During the Moderate Hypothermia
NCT03079492 ·Status: UNKNOWN
-
Systemic Hypothermia Improves Outcome of Hypoxic-Ischemic Encephalopathy
NCT00817401 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Whole-Body Hypothermia for Neonates With Hypoxic-Ischemic Encephalopathy(HIE)
NCT05581927 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy of Erythropoietin to Improve Survival and Neurological Outcome in Hypoxic Ischemic Encephalopathy
NCT01732146 ·Status: COMPLETED ·Phase: PHASE3
-
Cytokines Associated With Cord Blood Cell Therapy for Neonatal Encephalopathy
NCT02455830 ·Status: UNKNOWN
-
Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth
NCT02071394 ·Status: COMPLETED ·Phase: PHASE2
-
Does Placenta Pathology Predict Outcome of Neonates With Hypoxic Ischemic Encephalopathy?"
NCT03284528 ·Status: COMPLETED
-
Hypothermia During ECMO to Decrease Brain Injury
NCT01675388 ·Status: WITHDRAWN ·Phase: NA
-
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
NCT02793999 ·Status: RECRUITING
-
Correlation of Risk Factors and Severity of Hypoxic-ischaemic Encephalopathy
NCT02800018 ·Status: COMPLETED
-
The Ability of NIRS to Predict Brain Injury in Hypoxic Ischemic Encephalopathy
NCT03835039 ·Status: TERMINATED
-
Brain Imaging and Developmental Follow up of Infants Treated With Erythropoietin
NCT01207778 ·Status: COMPLETED
-
Cooling in Mild Encephalopathy
NCT05889507 ·Status: RECRUITING ·Phase: PHASE3
-
Hyperbaric Oxygen Therapy Improves Outcome of Hypoxic-Ischemic Encephalopathy
NCT02894866 ·Status: UNKNOWN ·Phase: NA
-
Effect of Erythropoietin in Premature Infants on White Matter Lesions and Neurodevelopmental Outcome
NCT03110341 ·Status: UNKNOWN ·Phase: PHASE3
-
Neonates with Hypoxic Ischemic Encephalopathy (HIE)
NCT06694545 ·Status: NOT_YET_RECRUITING
-
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
NCT01913340 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intravenous Immunoglobin Transfusion in Preterm Infants With Encephalopathy of Prematurity
NCT02822027 ·Status: UNKNOWN ·Phase: NA
-
Clinical Utility of Serum Biomarkers for the Management of Neonatal Hypoxic Ischemic Encephalopathy (Control Levels)
NCT02349672 ·Status: COMPLETED
-
Becoming Children With Perinatal Anoxo-Ischemic Encephalopathy Without Indication of Therapeutic Hypothermia
NCT03744481 ·Status: COMPLETED
-
Severity of Hypoxic Ischemic Encephalopathy and Neurological Pupil Index in Neonates
NCT07024771 ·Status: NOT_YET_RECRUITING
-
Reno-protective Effect of Brain Cooling in Newborn With Hypoxia
NCT02683915 ·Status: COMPLETED
-
Mesenchymal Stem Cells With Cooling Therapy for Infants With Hypoxic-Ischemic Encephalopathy
NCT07018739 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Erythropoietin in Management of Neonatal Hypoxic Ischemic Encephalopathy
NCT03163589 ·Status: UNKNOWN ·Phase: PHASE3